Your browser doesn't support javascript.
loading
Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Primary results from PALOMA-4.
Xu, Binghe; Hu, Xichun; Li, Wei; Sun, Tao; Shen, Kunwei; Wang, Shusen; Cheng, Ying; Zhang, Qingyuan; Cui, Shude; Tong, Zhongsheng; Geng, Cuizhi; Song, Erwei; Huang, Chiun-Sheng; Sriuranpong, Virote; Ngan, Roger K C; Chia, Yee H; Wang, Xinwei; Zhao, Huadong.
Affiliation
  • Xu B; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: xubinghe@medmail.com.cn.
  • Hu X; Fudan University Shanghai Cancer Center, Shanghai, China.
  • Li W; The First Hospital of Jilin University, Changchun, China.
  • Sun T; Cancer Hospital of China Medical University/Liaoning Cancer Hospital, Shenyang, Liaoning, China.
  • Shen K; Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang S; Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Cheng Y; Jilin Provincial Cancer Hospital, Changchun, China.
  • Zhang Q; Harbin Medical University Cancer Hospital/Oncology Department, Harbin, China.
  • Cui S; Henan Cancer Hospital, Zhengzhou, China.
  • Tong Z; Tianjin Cancer Hospital/Breast Cancer Department, Tianjin, China.
  • Geng C; Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
  • Song E; Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Huang CS; National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
  • Sriuranpong V; Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Ngan RKC; Department of Clinical Oncology, The University of Hong Kong, Hong Kong.
  • Chia YH; Tan Tock Seng Hospital, Singapore.
  • Wang X; Pfizer (China) R&D Co., Ltd., Shanghai, China.
  • Zhao H; Pfizer (China) R&D Co., Ltd., Shanghai, China.
Eur J Cancer ; 175: 236-245, 2022 11.
Article in En | MEDLINE | ID: mdl-36155117
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neutropenia Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neutropenia Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article Country of publication: